A293480 Stock Overview
Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 2/6 |
Hana Pharm Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩13,260.00 |
| 52 Week High | ₩16,190.00 |
| 52 Week Low | ₩13,170.00 |
| Beta | 0 |
| 1 Month Change | -2.43% |
| 3 Month Change | -3.98% |
| 1 Year Change | -14.51% |
| 3 Year Change | -44.22% |
| 5 Year Change | -43.47% |
| Change since IPO | -56.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| A293480 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -0.6% | -1.1% | -1.2% |
| 1Y | -14.5% | 0.8% | 3.0% |
Return vs Industry: A293480 underperformed the KR Pharmaceuticals industry which returned 0.8% over the past year.
Return vs Market: A293480 underperformed the KR Market which returned 3% over the past year.
Price Volatility
| A293480 volatility | |
|---|---|
| A293480 Average Weekly Movement | 2.1% |
| Pharmaceuticals Industry Average Movement | 4.7% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A293480 has not had significant price volatility in the past 3 months.
Volatility Over Time: A293480's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | n/a | Taehong Choi | www.hanaph.co.kr |
Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1996 and is headquartered in Seoul, South Korea.
Hana Pharm Co., Ltd. Fundamentals Summary
| A293480 fundamental statistics | |
|---|---|
| Market cap | ₩235.67b |
| Earnings (TTM) | ₩24.30b |
| Revenue (TTM) | ₩139.33b |
0.0x
P/E Ratio0.0x
P/S RatioIs A293480 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A293480 income statement (TTM) | |
|---|---|
| Revenue | ₩139.33b |
| Cost of Revenue | ₩45.33b |
| Gross Profit | ₩94.00b |
| Other Expenses | ₩69.70b |
| Earnings | ₩24.30b |
Last Reported Earnings
Dec 31, 2017
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A293480 perform over the long term?
See historical performance and comparison